E. Ohman J:or Asset Management’s Pfizer PFE Stock Holding History

E. Ohman J:or Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.79M	Hold	199,117	–	–	0.11%	102
2026 Q1	$5.59M	Buy	199,117 +58,500	+42%	+$1.56M	0.15%	91
2025 Q4	$3.5M	Buy	+140,617	New	+$3.55M	0.08%	117
2024 Q3	–	Sell	-243,000	Closed	-$6.8M	–	426
2024 Q2	$6.8M	Buy	+243,000	New	+$6.69M	0.17%	72
2021 Q4	–	Sell	-253,200	Closed	-$10.9M	–	487
2021 Q3	$10.9M	Buy	253,200 +10,400	+4%	+$461K	0.34%	55
2021 Q2	$9.51M	Buy	242,800 +21,900	+10%	+$852K	0.3%	62
2021 Q1	$8M	Buy	220,900 +107,700	+95%	+$3.82M	0.29%	64
2020 Q4	$4.17M	Sell	113,200 -15,177	-12%	-$557K	0.17%	86
2020 Q3	$4.47M	Buy	+128,377	New	+$4.5M	0.22%	73
2019 Q4	–	Sell	-263,468	Closed	-$8.98M	–	469
2019 Q3	$8.98M	Buy	263,468 +16,337	+7%	+$594K	0.57%	39
2019 Q2	$10.2M	Buy	247,131 +84,214	+52%	+$3.34M	0.67%	33
2019 Q1	$6.56M	Sell	162,917 -18,129	-10%	-$726K	0.44%	47
2018 Q4	$7.5M	Sell	181,046 -113,094	-38%	-$4.69M	0.55%	45
2018 Q3	$12.3M	Buy	294,140 +24,558	+9%	+$945K	0.8%	32
2018 Q2	$9.28M	Buy	269,582 +87,272	+48%	+$2.98M	0.66%	39
2018 Q1	$6.14M	Sell	182,310 -8,749	-5%	-$301K	0.49%	46
2017 Q4	$6.57M	Buy	191,059 +22,661	+13%	+$773K	0.53%	43
2017 Q3	$5.7M	Buy	168,398 +7,241	+4%	+$233K	0.51%	43
2017 Q2	$5.14M	Sell	161,157 -6,007	-4%	-$189K	0.52%	43
2017 Q1	$5.43M	Buy	167,164 +18,972	+13%	+$598K	0.67%	39
2016 Q4	$4.57M	Buy	148,192 +11,594	+8%	+$354K	0.64%	40
2016 Q3	$4.39M	Buy	136,598 +5,480	+4%	+$183K	0.65%	41
2016 Q2	$4.38M	Buy	131,118 +10,646	+9%	+$340K	0.73%	36
2016 Q1	$3.39M	Sell	120,472 -4,111	-3%	-$117K	0.61%	43
2015 Q4	$3.82M	Hold	124,583	–	–	0.67%	42
2015 Q3	$3.71M	Sell	124,583 -6,218	-5%	-$199K	1%	21
2015 Q2	$4.16M	Sell	130,801 -13,492	-9%	-$440K	0.97%	18
2015 Q1	$4.76M	Hold	144,293	–	–	1.1%	13
2014 Q4	$4.3M	Sell	144,293 -5,375	-4%	-$154K	1.02%	15
2014 Q3	$4.2M	Hold	149,668	–	–	1.03%	18
2014 Q2	$4.21M	Sell	149,668 -6,324	-4%	-$180K	1.03%	17
2014 Q1	$4.75M	Sell	155,992 -17,496	-10%	-$522K	1.18%	14
2013 Q4	$5.05M	Sell	173,488 -3,900	-2%	-$114K	1.19%	16
2013 Q3	$4.83M	Sell	177,388 -10,540	-6%	-$287K	1.22%	15
2013 Q2	$4.99M	Buy	+187,928	New	+$5.19M	1.37%	14

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

E. Ohman J:or Asset Management's PFE Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 199,117 shares worth $4.79M. The position accounts for 0.11% of the portfolio, ranked #102.

E. Ohman J:or Asset Management first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $12.3M in Q3 2018. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

E. Ohman J:or Asset Management held 199,117 shares of Pfizer worth $4.79M as of Q2 2026.
E. Ohman J:or Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.11% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #102 holding.
E. Ohman J:or Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
E. Ohman J:or Asset Management's Pfizer position peaked at $12.3M in Q3 2018.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.